000189737 001__ 189737
000189737 005__ 20210129215427.0
000189737 0247_ $$2doi$$a10.1007/s00259-015-3018-5
000189737 0247_ $$2ISSN$$a0340-6997
000189737 0247_ $$2ISSN$$a1432-105X
000189737 0247_ $$2ISSN$$a1619-7070
000189737 0247_ $$2ISSN$$a1619-7089
000189737 0247_ $$2WOS$$aWOS:000352232900012
000189737 037__ $$aFZJ-2015-02769
000189737 082__ $$a610
000189737 1001_ $$0P:(DE-HGF)0$$aCicone, Francesco$$b0$$eCorresponding Author
000189737 245__ $$aVolumetric assessment of recurrent or progressive gliomas: comparison between F-DOPA PET and perfusion-weighted MRI
000189737 260__ $$aHeidelberg [u.a.]$$bSpringer-Verl.$$c2015
000189737 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1429766335_1449
000189737 3367_ $$2DataCite$$aOutput Types/Journal article
000189737 3367_ $$00$$2EndNote$$aJournal Article
000189737 3367_ $$2BibTeX$$aARTICLE
000189737 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000189737 3367_ $$2DRIVER$$aarticle
000189737 520__ $$aPurposeTo compare the diagnostic information obtained with 6-[18F]-fluoro-l-3,4-dihydroxyphenylalanine (F-DOPA) PET and relative cerebral blood volume (rCBV) maps in recurrent or progressive glioma.MethodsAll patients with recurrent or progressive glioma referred for F-DOPA imaging at our institution between May 2010 and May 2014 were retrospectively included, provided that macroscopic disease was visible on conventional MRI images and that rCBV maps were available for comparison. The final analysis included 50 paired studies (44 patients). After image registration, automatic tumour segmentation of both sets of images was performed using the average signal in a large reference VOI including grey and white matter multiplied by 1.6. Tumour volumes identified by both modalities were compared and their spatial congruence calculated. The distances between F-DOPA uptake and rCBV hot spots, tumour-to-brain ratios (TBRs) and normalized histograms were also computed.ResultsOn visual inspection, 49 of the 50 F-DOPA and 45 of the 50 rCBV studies were classified as positive. The tumour volume delineated using F-DOPA (F-DOPAvol 1.6) greatly exceeded that of rCBV maps (rCBVvol 1.6). The median F-DOPAvol 1.6 and rCBVvol 1.6 were 11.44 ml (range 0 – 220.95 ml) and 1.04 ml (range 0 – 26.30 ml), respectively (p < 0.00001). Overall, the median overlapping volume was 0.27 ml, resulting in a spatial congruence of 1.38 % (range 0 – 39.22 %). The mean hot spot distance was 27.17 mm (±16.92 mm). F-DOPA uptake TBR was significantly higher than rCBV TBR (1.76 ± 0.60 vs. 1.15 ± 0.52, respectively; p < 0.0001). The histogram analysis showed that F-DOPA provided better separation of tumour from background. In 6 of the 50 studies (12 %), however, physiological uptake in the striatum interfered with tumour delineation.ConclusionThe information provided by F-DOPA PET and rCBV maps are substantially different. Image interpretation is easier and a larger tumour extent is identified on F-DOPA PET images than on rCBV maps. The clinical impact of such differences needs to be explored in future studies.
000189737 536__ $$0G:(DE-HGF)POF3-573$$a573 - Neuroimaging (POF3-573)$$cPOF3-573$$fPOF III$$x0
000189737 588__ $$aDataset connected to CrossRef, juser.fz-juelich.de
000189737 7001_ $$0P:(DE-Juel1)141877$$aFilss, Christian$$b1
000189737 7001_ $$0P:(DE-HGF)0$$aMinniti, Giuseppe$$b2
000189737 7001_ $$0P:(DE-HGF)0$$aRossi-Espagnet, Camilla$$b3
000189737 7001_ $$0P:(DE-HGF)0$$aPapa, Annalisa$$b4
000189737 7001_ $$0P:(DE-HGF)0$$aScaringi, Claudia$$b5
000189737 7001_ $$0P:(DE-Juel1)143792$$aGalldiks, Norbert$$b6
000189737 7001_ $$0P:(DE-HGF)0$$aBozzao, Alessandro$$b7
000189737 7001_ $$0P:(DE-Juel1)131794$$aShah, N. J.$$b8
000189737 7001_ $$0P:(DE-HGF)0$$aScopinaro, Francesco$$b9
000189737 7001_ $$0P:(DE-Juel1)131777$$aLangen, Karl-Josef$$b10
000189737 773__ $$0PERI:(DE-600)2098375-X$$a10.1007/s00259-015-3018-5$$gVol. 42, no. 6, p. 905 - 915$$n6$$p905 - 915$$tEuropean journal of nuclear medicine and molecular imaging$$v42$$x1619-7089$$y2015
000189737 8564_ $$uhttps://juser.fz-juelich.de/record/189737/files/art_10.1007_s00259-015-3018-5.pdf$$yRestricted
000189737 8564_ $$uhttps://juser.fz-juelich.de/record/189737/files/art_10.1007_s00259-015-3018-5.gif?subformat=icon$$xicon$$yRestricted
000189737 8564_ $$uhttps://juser.fz-juelich.de/record/189737/files/art_10.1007_s00259-015-3018-5.jpg?subformat=icon-1440$$xicon-1440$$yRestricted
000189737 8564_ $$uhttps://juser.fz-juelich.de/record/189737/files/art_10.1007_s00259-015-3018-5.jpg?subformat=icon-180$$xicon-180$$yRestricted
000189737 8564_ $$uhttps://juser.fz-juelich.de/record/189737/files/art_10.1007_s00259-015-3018-5.jpg?subformat=icon-640$$xicon-640$$yRestricted
000189737 8564_ $$uhttps://juser.fz-juelich.de/record/189737/files/art_10.1007_s00259-015-3018-5.pdf?subformat=pdfa$$xpdfa$$yRestricted
000189737 909CO $$ooai:juser.fz-juelich.de:189737$$pVDB
000189737 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)141877$$aForschungszentrum Jülich GmbH$$b1$$kFZJ
000189737 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)143792$$aForschungszentrum Jülich GmbH$$b6$$kFZJ
000189737 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131794$$aForschungszentrum Jülich GmbH$$b8$$kFZJ
000189737 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131777$$aForschungszentrum Jülich GmbH$$b10$$kFZJ
000189737 9130_ $$0G:(DE-HGF)POF2-332$$1G:(DE-HGF)POF2-330$$2G:(DE-HGF)POF2-300$$aDE-HGF$$bGesundheit$$lFunktion und Dysfunktion des Nervensystems$$vImaging the Living Brain$$x0
000189737 9131_ $$0G:(DE-HGF)POF3-573$$1G:(DE-HGF)POF3-570$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lDecoding the Human Brain$$vNeuroimaging$$x0
000189737 9141_ $$y2015
000189737 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR
000189737 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000189737 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000189737 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000189737 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000189737 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000189737 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000189737 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000189737 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000189737 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000189737 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5
000189737 9201_ $$0I:(DE-Juel1)INM-4-20090406$$kINM-4$$lPhysik der Medizinischen Bildgebung$$x0
000189737 9201_ $$0I:(DE-Juel1)INM-3-20090406$$kINM-3$$lKognitive Neurowissenschaften$$x1
000189737 980__ $$ajournal
000189737 980__ $$aVDB
000189737 980__ $$aI:(DE-Juel1)INM-4-20090406
000189737 980__ $$aI:(DE-Juel1)INM-3-20090406
000189737 980__ $$aUNRESTRICTED
000189737 981__ $$aI:(DE-Juel1)INM-3-20090406